Skip to content
Home/Companies/Healthcare/Lykon

Lykon

Healthcare·Germany·Exited 2024·Held 2yr
Entry
2022
Hold
2yr
Exit
2024

Who owns Lykon?

Lykon was owned by Zintinus through Zintinus Fund I (2021 vintage) from 2022 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Zintinus
Investor
Zintinus
Zintinus Fund I · 2021 · VC

Key facts

HQGermany
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from Zintinus Fund I

Other portfolio companies in the same fund.

KAAPA Biotech
Active
HealthcareFinland· 2025
NEOH
NEOH
Active
FoodTechAustria· 2025
Blue Stripes
Blue Stripes
Active
ConsumerUS· 2024
Kitro
Active
Business ServicesSwitzerland· 2024
Planet A Foods
Planet A Foods
Active
ConsumerGermany· 2024
Planted
Active
ConsumerSwitzerland· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Lykon

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Lykon?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Lykon.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue